These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 945068)

  • 41. Specificity of trypsin and chymotrypsin: loop-motion-controlled dynamic correlation as a determinant.
    Ma W; Tang C; Lai L
    Biophys J; 2005 Aug; 89(2):1183-93. PubMed ID: 15923233
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Crystal structures of bovine chymotrypsin and trypsin complexed to the inhibitor domain of Alzheimer's amyloid beta-protein precursor (APPI) and basic pancreatic trypsin inhibitor (BPTI): engineering of inhibitors with altered specificities.
    Scheidig AJ; Hynes TR; Pelletier LA; Wells JA; Kossiakoff AA
    Protein Sci; 1997 Sep; 6(9):1806-24. PubMed ID: 9300481
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Modelling of the serine-proteinase fold by X-ray and neutron scattering and sedimentation analyses: occurrence of the fold in factor D of the complement system.
    Perkins SJ; Smith KF; Kilpatrick JM; Volanakis JE; Sim RB
    Biochem J; 1993 Oct; 295 ( Pt 1)(Pt 1):87-99. PubMed ID: 8216242
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Trypsin: a case study in the structural determinants of enzyme specificity.
    Hedstrom L
    Biol Chem; 1996; 377(7-8):465-70. PubMed ID: 8922280
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Application of pulse radiolysis to the study of proteins: chymotrypsin and trypsin.
    Faraggi M; Klapper MH; Dorfman LM
    Biophys J; 1978 Oct; 24(1):307-17. PubMed ID: 708836
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Activation of bovine factor X (Stuart factor)--analogy with pancreatic zymogen-enzyme systems.
    Kerr MA; Grahn DT; Walsh KA; Neurath H
    Biochemistry; 1978 Jun; 17(13):2645-8. PubMed ID: 678535
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Catalytic properties of serine proteases. 2. Comparison between human urinary kallikrein and human urokinase, bovine beta-trypsin, bovine thrombin, and bovine alpha-chymotrypsin.
    Ascenzi P; Menegatti E; Guarneri M; Bortolotti F; Antonini E
    Biochemistry; 1982 May; 21(10):2483-90. PubMed ID: 7046788
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Further studies on lipopolysaccharide-sensitive serine protease zymogen (factor C): its isolation from Limulus polyphemus hemocytes and identification as an intracellular zymogen activated by alpha-chymotrypsin, not by trypsin.
    Tokunaga F; Nakajima H; Iwanaga S
    J Biochem; 1991 Jan; 109(1):150-7. PubMed ID: 2016264
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Properties of the histidine residues of indole-chymotrypsin. Implications for the activation process and catalytic mechanism.
    Cruickshank WH; Kaplan H
    Biochem J; 1975 Jun; 147(3):411-16. PubMed ID: 241327
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The crystal and molecular structure of DIP-inhibited bovine trypsin at2.7Angstrom resolution.
    Stroud RM; Kay LM; Dickerson RE
    Cold Spring Harb Symp Quant Biol; 1972; 36():125-40. PubMed ID: 4508129
    [No Abstract]   [Full Text] [Related]  

  • 51. Covalent structure of a group-specific protease from rat small intestine. Appendix: crystallographic data for a group specific protease from rat intestine.
    Woodbury RG; Katunuma N; Kobayashi K; Titani K; Neurath H; Anderson WF; Matthews BW
    Biochemistry; 1978 Mar; 17(5):811-9. PubMed ID: 629933
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Exposure of the tyrosyl and tryptophyl residues in trypsin and trypsinogen.
    Villanueva GB; Herskovits TT
    Biochemistry; 1971 Aug; 10(18):3358-65. PubMed ID: 5165784
    [No Abstract]   [Full Text] [Related]  

  • 53. The effect of cleaving the reactive-site peptide bond Lys-15--Ala-16 on the conformation of bovine trypsin-kallikrein inhibitor (K unitz) as revealed by solvent-perturbation spectra, circular dichroism and fluorescence.
    Quast U; Engel J; Steffen E; Tschesche H; Jering H; Kupfer S
    Eur J Biochem; 1975 Apr; 52(3):511-4. PubMed ID: 1242086
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Converting trypsin to chymotrypsin: residue 172 is a substrate specificity determinant.
    Hedstrom L; Perona JJ; Rutter WJ
    Biochemistry; 1994 Jul; 33(29):8757-63. PubMed ID: 8038165
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Serine hydroxymethyltransferase. Effect of proteases on the activity and structure of the cytosolic enzyme.
    Schirch V; Schirch D; Martini F; Bossa F
    Eur J Biochem; 1986 Nov; 161(1):45-9. PubMed ID: 3536510
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Probes of the mechanism of zymogen catalysis.
    Lonsdale-Eccles JD; Neurath H; Walsh KA
    Biochemistry; 1978 Jul; 17(14):2805-9. PubMed ID: 687564
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Comparative study of the properties of serine proteases of lower and higher vertebrates].
    Kolodzeĭskaia MV; Berevka SV
    Ukr Biokhim Zh (1978); 1990; 62(6):31-7. PubMed ID: 2087790
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Catalysis by chymotrypsinogen. Demonstration of an acyl-zymogen intermediate.
    Gertler A; Walsh KA; Neurath H
    Biochemistry; 1974 Mar; 13(6):1302-10. PubMed ID: 4856029
    [No Abstract]   [Full Text] [Related]  

  • 59. Mapping the suramin-binding sites of human neutrophil elastase: investigation by fluorescence resonance energy transfer and molecular modeling.
    Mély Y; Cadène M; Sylte I; Bieth JG
    Biochemistry; 1997 Dec; 36(50):15624-31. PubMed ID: 9398290
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Gamma-irradiated chymotrypsin-like proteins. I. Structural changes.
    Bezrukova AG; Ostashevsky IY
    Int J Radiat Biol Relat Stud Phys Chem Med; 1977 Feb; 31(2):131-44. PubMed ID: 300718
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.